Driving the Best Science to Meet Global Health Challenge s

O.4.5.4.002 
NS1 rapid test for detection of dengue virus infection
15 .45
 
 B .-T . Teoh, S .-S . Sam, K .-K . Tan, J . Johari, J . Abd-Jamil, 
S . Abubakar (Kuala Lumpur, MY) 
O.4.5.4.003 
A school-based intervention trial using insecticide-treated
16 .00
 
school uniforms to reduce dengue infections in school-aged 
children
P . Kittayapong, P . Olarantmanee, P . Maskao, P . Byass, W . Lohr, 
D . Gubler, A . Wilder-Smith (Bangkok, Chachaengso, TH; 
Umea, SE; Singapore, SG) 
O.4.5.4.004 
Household-related risk factors of tungiasis and severe 
16 .15
 
disease in Kilifi County, Kenya
S . Wiese, H . Feldmeier, L . Elson, P .S . Larson, B . Mambo (Berlin, 
DE; Mombasa, Watamu, KE; Nagasaki, JP; Ann Arbor, US) 
O.4.5.4.005 
Topically applied dimeticones are highly effective against 
16 .30
 
embedded sand fleas (T. penetrans)
H . Feldmeier, M . Thielecke, P . Nordin, N . Ngomi, G . Mukone 
(Berlin, DE; Skövde, SE; Nairobi, KE; Kampala, UG) 
O.4.5.4.006 
Efficacy of deltamethrin applied as ULV- and thermal 
16 .45
 
aerosols for control of Aedes albopictus in Nice, France
S .C . Boubidi, D . Roiz, M . Rossignol, R . Benoit, M . Raselli, 
C . Tizon, B . Cadiou, R . Tounsi, C . Lagneau, F . Chandre, 
D . Fontenille, P . Reiter (Montpellier, Paris, FR; Phnom Penh, KH) 

45
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
15 .30 – 17 .00
 
Parallel Session 3.3.3. 
Samarkand
 
(Disease systems) 
 
NCDs with particular relevance to mental health 
 
Convener and Chair: Meichun Mohler-Kuo (Zurich, CH) 
INV.3.3.3.001 
No health without mental health
15 .30
 
Emiliano Albanese (Geneva, CH) 
O.3.3.3.002 
Depression in people living with HIV/AIDS in Fitche 
16 .00
 
Hospital, Central Ethiopia: a cross-sectional study 
T . Yeneabat, B . Tolasa (Debre Markos, Fitche, ET) 
O.3.3.3.003 
Mental health problems of undocumented migrants in 
16 .15
 
the Netherlands: a qualitative exploration of help-seeking 
behaviour and experiences with primary care
E . Teunissen, J . Sherally, E . van Weel-Baumgarten, M . van den 
Muijsenbergh (Nijmegen, NL) 
O.3.3.3.004 
The effect of vitamin B1 on anxiety associated with 
16 .30
 
premenstrual syndrome in young women in Iran
S . Abdollahifard, M . Maddahfar (Jahrom, Tehran, IR) 
O.3.3.3.005 
A qualitative study of the social response to patients and 
16 .45
 
caretakers of mental health disorders in a rural community 
of Maharashtra, India
R . Sharma, N .F . Mistry, N . Sule, M . Weiss (Pune, IN; Basel, CH) 
17 .00 – 17 .30
 
Plenary Session 4 
San Francisco 
 
From research to implementation
 
Chair: David Brandling-Bennett (Seattle, US) 
PL4.001 
Systems biology of plasmodium; a window into malaria 
parasite pathophysiology and pathogenesis
Zbynek Bozdech (Singapore, SG) 

46
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
17 .00 – 18 .00
 
Poster Speed Talks 2 
Montreal 
 
NCDs and reproductive health 
 
Chair: Kate Molesworth (Basel, CH) 
PST2.001 
Patterns and determinants of longitudinal changes in 
17 .00
 
smoking behaviour in Switzerland between 1991 and 2011: 
results from the SAPALDIA cohort
D . Ayala-Bernal, N . Probst-Hensch, N . Künzli, L . Perez, 
A . Vicedo-Cabrera, D . Stolz, T . Rochat, C . Schindler (Basel, 
Geneva, CH) 
PST2.002 
Characterizing diabetes in Palestine: a pilot study
17 .05
 
A . Alkaiyat, S . Hamshari (Basel, CH; Nablus, PS) 
PST2.003 
Hospital-acquired versus community-acquired MRSA 
17 .10
 
in Singapore 
P .F . de Sessions, L .K . Lee, L .Y . Sin, A .C . Li Ping, M .H . Hibberd 
(Singapore, SG; London, GB) 
PST2.004 
Timing of delivery and smoke-free laws in Switzerland
17 .15
 
 A .M . Vicedo-Cabrera, C .S . Schindler, D .R . Radovanovic, 
M . Röösli, L . Perez (Basel, Zurich, CH) 
PST2.005 
Extended spectrum beta lactam resistance among gram 
17 .20
 
negative bacterial isolates from wounds of patients 
attending a Ghanaian Hospital
G . Kpeli, E . Owusu-Mireku, J . Hauser, V . Hinic, E . Danso, 
R . Frei, G . Pluschke, D . Yeboah-Manu (Legon, GH; Basel, CH) 
PST2.006 
Estimation of concentrations of six anti-malarial drugs in
17 .25
 
human breast milk based on their physicochemical and 
protein binding characteristics
J .P . Jain, V .P . Marasanapalle, D . Saudari, G . Sunkara 
(Hyderabad, IN; East Hanover, US) 
PST2.007 
Human and animal trematode infections at Lake Chad: 
17 .30
 
a one health approach to schistosomiasis and fascioliasis 
in mobile pastoralists and their livestock
H . Greter, A .A . Batil, S .J . Krauth, I .O . Alfaroukh, J . Utzinger, 
J . Zinsstag (Basel, CH; N‘Djaména, TD) 
PST2.008 
Reduced all-cause child mortality after general measles 
17 .35
 
vaccination campaign in rural Guinea-Bissau
A .B . Fisker, A . Rodrigues, C . Martins, H . Ravn, S . Byberg, 
S . Thysen, L . Storgaard, M . Pedersen, M . Fernandes, C .S . Benn, 
P . Aaby (Copenhagen S, DK; Bissau, GW) 
PST2.009 
Factors affecting childhood diarrhoea and pneumonia 
17 .40
 
care-seeking behavior of mothers in a coastal area of 
Bangladesh
A . Haque, S . Shaha (Dhaka, BD) 
PST2.010 
Pregnancy in adolescence in the Great Lakes region: 
17 .45
 
findings from a multi-country survey in South Kivu (DRC), 
Burundi and Rwanda
J . Schwarz, C . Blake, N . Ndabihore, C . Weiss, A . Martin Hilber, 
S . Merten (Basel, CH; Bujumbura, BI) 

47
SCIENTIFIC PROGRAMME 
Monday, 7 September 2015
Scientific Pr
og
ramme
17 .30 – 18 .00
 
Plenary Session 5 
San Francisco 
 
Disease Systems 
 
Chair: Jürg Utzinger (Basel, CH) 
PL5.001 
Neglected diseases, neglected people and neglected 
systems
Vincent Belizario (Manila, PH) 
18 .15 – 19 .30
 
Meet the editors of PLoS neglected 
Boston 1 
 
tropical diseas and O & A
 
Chair: Jennifer Keiser (Basel, CH) 
 
Chair: Jürg Utzinger (Basel, CH) 
18 .15 – 19 .45
 
Film Presentation 
Montreal 
 
Can film save lives?
Please refer to the ECTMIH mobile app for further details

48
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
09 .00 – 09 .30
 
Plenary Session 6 
San Francisco 
 
From research to implementation
 
Chair: Joanna Schellenberg (London, GB) 
PL6.001 
From mapping to risk profiling to predictions and 
interventions
Penelope Vounatsou (Basel, CH) 
09 .30 – 10 .00
 
Plenary Session 7 
San Francisco 
 
Health and social systems 
 
Chair: Núria Casamitjana (Barcelona, ES) 
INV.PL7.001 
Gender sensitivity in health systems: why does it matter?
C . Vlassoff (Ottawa, CA) 
10 .30 – 12 .00
 
Society Session 3 
San Francisco 
 
Société de Pathologie Exotique (SPE), Italian Society 
of Tropical Medicine and Global Health (SIMET) and 
Sociedad Española de Medicina Tropical y Salud 
Internacional (SEMTSI): Rapid diagnosis tests (RDTs) 
in tropical infectiology 2 
 
Chair: Miriam Navarro (Madrid, ES)  
 
Chair: Federico Gobbi (Negrar, IT) 
SS3.001 
Rapid diagnostic tests for Chagas disease: an overview
10 .30
 
Andrea Angheben (Negrar, IT) 
SS3.002 
The need for a rapid diagnostic test for Strongyloides 
10 .50
 stercoralis
Joan Gomez (Barcelona, ES) 
SS3.003 
Rapid tests for the diagnosis of Dengue and Chikungunya: 
11 .10
 
strengths and weaknesses
Isabelle Leparc-Goffart (Marseille, FR) 
SS3.004 
Rapid tests for the diagnosis of Dengue and Chikungunya: 
11 .30
 
a case series from a tertiary Italian hospital
Guido Calleri (Torino, IT) 
11 .50
 Discussion 

49
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
Scientific Pr
og
ramme
10 .30 – 12 .00
 
Parallel Session 5.3.3. 
Sydney 
 
(From research to implementation) 
 
Where there is no market – exploring novel 
 approaches to R&D for diseases of the poor 
 
Convener and Chair: Manica Balasegaram (Geneva, CH)  
 
Convener and Chair: Alexander Schulze (Berne, CH) 
INV.5.3.3.001 
Global health R&D needs and gaps – which options do we
10 .30
 
have to address them?
John-Arne Röttingen (Oslo, NO) 
INV.5.3.3.002 
Conceptualizing a health R&D pooled fund for voluntary 
10 .50
 contributions
John Reeder (Geneva, CH) 
O.5.3.3.003 
The challenge of product R&D initiatives for neglected
11 .10
 
tropical diseases that currently rely on product donation 
programs
J . Reinhard-Rupp, J . Lazdins (Coinsins, CH) 
O.5.3.3.004 
Looking at alternative models for innovation and access 
11 .25
 
for neglected infectious diseases
M . Balasegaram (Geneva, CH) 
O.5.3.3.005 
Cell-based drug discovery model at the Novartis Institute
11 .40
 
for Tropical Diseases using Human African 
Trypanosomiasis as an example
D . Beer, M . Barrett, D . Begolo, C . Clayton, J . Jiricek, M . Kaiser, 
H . Koh, C . Kounde, S . Lakshminarayana, V . Manoharan, 
J . Mottram, E . Myburgh, P . Ng, S . Rao, M . Schirle, S . Tania, 
J . Thomas, P . Vachaspati, I . Vincent, P . Wipfli, J . Wong, 
P . Maser, T . Diagana (Singapore, SG; Glasgow, GB; Heidelberg, 
DE; Basel, CH; Cambridge, US) 

50
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
10 .30 – 12 .00
 
Parallel Session 4.4.1. 
Singapore
 
(Health and social systems) 
 
Emergent diseases: Immigrants and potential 
diseases with impact in and for Europe 
 
Convener and Chair: Eduardo Gotuzzo (Lima, PE) 
INV.4.4.1.001 
Emergent diseases: immigrants and potential diseases with
10 .30
 
impact in and for Europe
Alessandro Bartoloni (Florence, IT) 
O.4.4.1.002 
Dengue serotypes and genotypes circulating in recent 
11 .00  
years in the Caribbean and imported to Europe
L . Franco, M .D . Fernandez, N . Serre, M . Martinez, E . Sulleiro, 
A . Neumayr, F . Molero, M . Schunk, C . Guido, A . Wilder-Smith, 
C . Hatz, M .P . Sanchez-Seco (Barcelona, Madrid,ES; Dakar, SN; 
Basel, CH; Munich, DE; Torino, IT; Umea, SE)
O.4.4.1.003 
Identification of potential novel P. vivax vaccine candi-
11 .15
 
dates: naturally-acquired immune responses to a panel of 
P. vivax blood-stage antigens are associated with reduced 
risk of clinical malaria episodes in Papua New Guinean 
children
C . França, J . Hostetler, W . He, L .J . Robinson, E . Lin, C .S .N . Li 
Wai Suen, S . Sharma, J . Gruszczyk, I . Malhotra, G . Frato, 
P . Siba, M . Galinski, J . Kazura, L . Schofield, G . Wright, 
W .H . Tham, E . Takashima, T . Tsuboi, R .M . Fairhurst, J . Rayner, 
C .L . King, I . Mueller (Melbourne, Townsville, AU; Hinxton, GB; 
Atlanta, Bethesda, Cleveland, US; Madang, PG; Matsuyama, 
JP; Barcelona, ES) 
O.4.4.1.004 
Mathematical models for P. vivax elimination 
11 .30
 
 S . Karl, M . White, G . Milne, I . Mueller (Melbourne, Perth, AU; 
London, GB) 
O.4.4.1.005 
Prevalence of strongyloidiasis in immigrants and in the
11 .45
 
autochthonous, elderly population in a formerly endemic 
area of Northern Italy
D . Buonfrate, M . Baldissera, N . Scattolo, G . Caramaschi, M . 
Giobbia, C . Maurel, M . Merelli, P . Rodari, G . Napoletano, Z . 
Bisoffi (Brescia, Mantua, Treviso, Triest, Udine, Verona, IT;

51
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
Scientific Pr
og
ramme
10 .30 – 12 .00
 
Parallel Session 3.1.5. 
Montreal
 
(Disease systems) 
 
Malaria transmission: from the field to the bench 
 
Convener and Chair: Ingrid Felger (Basel, CH) 
INV.3.1.5.001 
The human infectious reservoir for P. falciparum in African
10 .30
 settings
Teun Bousema (Nijmegen, NL) 
O.3.1.5.002 
Where to start malaria elimination: core or fringes?
11 .00
 
 N . Chitnis, A . Schapira, C . Schindler, M . Penny, T . Smith  
(Basel, CH) 
O.3.1.5.003 
Comparative transmission-stage dynamics of Plasmodium
11 .15
 
vivax and P. falciparum 
R . Wampfler, N . Hofmann, S . Karl, M . Silkey, L .J . Robinson, 
I . Mueller, I . Felger (Basel, CH; Melbourne, AU; Madang & 
Maprik, PG) 
O.3.1.5.004 
Impact of intensified malaria control on the epidemiology 
11 .30
 
and transmission of malaria in two areas of Papua New 
Guinea
L .J . Robinson, M . Ome-Kaius, C . Koepfli, J .H . Kattenberg, C . Li 
Wai Suen, D . Mantila, B . Kombut, M . Phillip, E . Malau, S . Jally, 
B . Kasien, S . Maripal, P . Siba, D . Tisch, C .L . King, I . Felger, 
J .W . Kazura, I . Mueller (Goroka, Madang, PG; Melbourne, AU; 
Cleveland, US; Basel, CH; Barcelona, ES) 
O.3.1.5.005 
Malaria prevalence and mosquito establishment in 
11 .45
 
Nouakchott, Mauritania
M .S . Ould Ahmedou Salem, A . Mint Mohamed Lemine, 
K . Mint Lekweiry, J . Mint Deida, O . Faye, H . Bogreau, 
L .K . Basco, F . Simard, A . O . Mohamed Salem Boukhary 
(Nouakchott, MR; Dakar, SN; Guyane, Marseille, Montpellier, 
Paris, FR) 

52
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
10 .30 – 12 .00
 
Parallel Session 3.2.9. 
Delhi
 
(Disease systems) 
 
Helminth infections – burden and impact 
 
Convener and Chair: Jennifer Keiser (Basel, CH) 
INV.3.2.9.001 
Helminth infections – burden and impact
10 .30
 
C .H . King (Cleveland, US) 
INV.3.2.9.002 
Onchocerciasis in the DRC and patient needs
10 .55
 
Didier Bakajika (Haywards Health, GB) 
O.3.2.9.003 
The impact of soil transmitted helminth on malaria clinical
11 .15
 
presentation and treatment outcome: a case control study 
among children in Bagamoyo district, coastal region of 
Tanzania
N .S . Masoud, N . Lenz, T . Schindler, S . Knopp, O . Lweno, 
U . Abdul, A . Mohamed, J . Rothen, J . Masimba, D . Kwaba, 
A .S . Mohammed, F . Althaus, S . Abdulla, M . Tanner, 
C . Daubeunberger, B . Genton (Bagamoyo, Dar es Salaam, TZ; 
Basel, Lausanne, CH) 
O.3.2.9.004 
Factors driving co-occurrence of Schistosoma mansoni and
11 .30
 
S. haematobium at the micro-geographical level
L . Meurs, M . Mbow, M . Yazdanbakhsh, K . Polman (Antwerp, 
BE; Dakar, SN; Leiden, NL) 
O.3.2.9.005 
Impact of preventive chemotherapy on burden of disease 
11 .45
 
due to helminthiasis: the lesson from Zanzibar
S .M . Ali, M . Albonico, A . Montresor, D . Molyneux, L . Savioli 
(Pemba, Zanzibar, TZ; Milan, IT; Geneva, CH; Liverpool, GB) 

53
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
Scientific Pr
og
ramme
10 .30 – 12 .00
 
Parallel Session 4.2.4. 
Boston 1
 
(Health and social systems) 
 
Promoting multi-sectorial approaches in health:  
what kind of science do we need? 
 
Convener and Chair: Susanna Hausmann (Berne, CH) 
INV.4.2.4.001 
One Health: the added value of cross-sectoral collaboration
10 .30
 
between human and animal health 
Jakob Zinsstag (Basel, US) 
O.4.2.4.002 
Cross-sectoral partnerships for health in real-life: a case
11 .00
 
study of the Global Fund’s country coordinating 
mechanism (CCM) in Ethiopia
H . Taddese, P . Bissell, A . Barnes, G . Jones (Sheffield, GB) 
O.4.2.4.003 
A qualitative evaluation of stakeholder perspectives on 
11 .15
 
the Millennium Village Project successes and challenges in 
Sauri, Kenya
Y . Ruiz, E .Y . Kim, A .N . Morse, Y . Tozan (New York, West 
Lafayette, US; Heidelberg, DE) 
O.4.2.4.004 
The living and working conditions including accessibility 
11 .30
 
to healthcare of migrants working in rubber plantations in 
eastern Thailand
P . Maskhao, S . Ninhanomchai, S . Khaklang, S . Thongyuan, 
L . Sringernyuang, P . Kittayapong (Chachoengsao, TH) 
O.4.2.4.005 
Using regional socio-ecologic models to identify system 
11 .45
 
barriers and enablers for the adoption of Improved Cook 
Stoves in rural Peru
D . Mäusezahl, S . Hartinger, J . Muela, J . Wolf, A . Powell, 
V . Baquerizo, V . Paz-Soldan (Basel, Neuchâtel, CH; Lima, PE; 
New Orleans, US) 
10 .30 – 12 .00
 
Parallel Session 3.6.2. 
Boston 2
 
(Disease systems) 
 Nutrition 
 
Convener and Chair: Klaus Kraemer (Basel, CH) 
INV.3.6.2.001 
Overview on nutrition and immunology – role of 
10 .30
 micronutrients
Charles Stephensen (Davis, US) 
INV.3.6.2.002 
Vitamin D and tuberculosis
10 .50
 
A .R . Martineau (London, GB) 
INV.3.6.2.003 
Iron fortification and the infant gut microbiome
11 .10
 
Michael Zimmermann (Zurich, CH) 
INV.3.6.2.004 
New insights into the role of iron in the etiology and 
11 .30
 
pathogenesis of malaria, severe anaemia and invasive 
bacteraemia
H . Verhoef (London, GB; Wageningen, NL; Keneba, GM) 

54
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
10 .30 – 12 .00
 
Parallel Session 5.4.1. 
Shanghai 1
 
(From research to implementation) 
 
Threats to health systems – emergency situations 
 
Convener and Chair: Nicolaus Lorenz (Basel, CH)  
 
Convener and Chair: Kaspar Wyss (Basel, CH) 
INV.5.4.1.001 
Evidence Aid: a resource for those preparing for and 
10 .30
 
responding to disasters, humanitarian crises and major 
healthcare emergencies 
C . Allen, M .J . Clarke (Belfast, Oxford, GB) 
O.5.4.1.002 
Pandemic preparedness, disease surveillance and health
11 .00
 
systems in West Africa: the case of The Gambia
J . Balen, Y . Masunaga, F . Jaiteh, U . d‘Alessandro (Sheffield, 
GB; Fajara, GM) 
O.5.4.1.003 
Environmental factors and fatal injuries during Typhoon
11 .15
 
Haiyan: a framework for assessing impact, mitigating risk, 
and promoting resilience during natural disasters
S .O . Sangalang (Cologne, DE) 
O.5.4.1.004 
Trends and factors associated with dengue mortality and 
11 .30
 
fatality in Brazil
E .S . da Paixão, M .D .C .N . Costa, D . Rasella, L . Cardim, 
A . Brasileiro, M .D .G .L .C . Teixeira (Salvador, BR) 
O.5.4.1.005 
Maintaining low mortality rates in displaced populations: 
11 .45
 
MSF experience in Minkaman
M . Rull, S . Masson, N . Peyraud, M . Simonelli, A . Ventura, 
C . Dorion, F . Luquero, I . Ciglenecki (Geneva, CH; Paris, FR) 
10 .30 – 11 .30
 
Tropical Medicine & International 
Shanghai 2 
 
Health (TMIH) Workshop 3 
 
What authors need to know: ethics of writing,  
and how journals tick 
Organizer: Susanne Groener (London, GB) 

55
SCIENTIFIC PROGRAMME 
Tuesday, 8 September 2015
Scientific Pr
og
ramme
10 .30 – 12 .00
 
Late Breaker Abstract Session 2 
Kairo 1 
 
Chair: Melissa Penny (Basel, CH) 
 
Chair: Manuel Hetzel (Basel, CH)
O.LB2.001 
Acceptability of plasma donation for clinical trial on Ebola 
10 .30